Has James Campau, DO received payments from drug or device companies?

Yes. Drug and device makers reported $32,354 in general payments to James Campau, DO across 1,213 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Campau, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Campau, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Campau, DO

Family Medicine · Bay City, MINPI 1932147758

Payments from drug & device makers

$32,354in general payments, 2019–2025

Across 1,213 payments — averaging $26.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$15K
AbbVie$2K
Lilly USA, LLC$2K
Novo Nordisk$2K
Pfizer$1K
Johnson & Johnson$978
plus $9K from 52 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	97	$15,047
AbbVie(2 entities)	112	$2,391
Lilly USA, LLC	157	$1,900
Novo Nordisk	144	$1,654
Pfizer	105	$1,274
Johnson & Johnson(2 entities)	44	$978
Amgen	52	$932
GSK	78	$740
Novartis	31	$592
Sanofi-aventis U.S. LLC	44	$562
Dexcom, Inc.	22	$458
Takeda Pharmaceuticals U.S.A., Inc.	26	$449
Astellas Pharma US Inc	19	$424
Bayer	32	$417
Merck	24	$389
Boehringer Ingelheim	18	$376
Corcept Therapeutics	19	$279
Abbott	13	$262
Axsome Therapeutics, Inc.	11	$250
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	15	$226
Vanda Pharmaceuticals Inc.	9	$220
Biohaven Pharmaceuticals, Inc.	7	$218
Otsuka America Pharmaceutical, Inc.	12	$215
Amarin Pharma, Inc.	11	$173
Radius Health, Inc.	7	$142
Lundbeck LLC	7	$141
Esperion Therapeutics, Inc.	7	$138
Exact Sciences	6	$136
E.r. Squibb & Sons, L.L.C.	7	$121
Mylan Specialty L.p.	6	$98
Phathom Pharmaceuticals, Inc.	5	$96
Xeris Pharmaceuticals, Inc.	6	$95
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$91
Biohaven Pharmaceutical Holding Company Ltd.	4	$91
Teva Pharmaceuticals USA, Inc.	5	$80
Seqirus USA Inc	4	$70
Dermira, Inc.	3	$68
Kowa Pharmaceuticals America, Inc.	4	$53
Insulet Corporation	2	$47
Currax Pharmaceuticals LLC	3	$41
Nalpropion Pharmaceuticals LLC	3	$40
Bioventus LLC	2	$35
Boston Scientific	2	$34
Sunovion Pharmaceuticals Inc.	5	$33
Corium, LLC	2	$33
RGH Enterprises LLC	1	$30
Biodelivery Sciences International, Inc.	2	$29
Medtronic	2	$25
Sanofi Pasteur Inc.	1	$19
Nestle Healthcare Nutrition Inc.	1	$19
Hologic Sales And Service, LLC	1	$18
Edwards Lifesciences	1	$17
Alkermes, Inc.	1	$17
Ironwood Pharmaceuticals, Inc	1	$17
Inspire Medical Systems, Inc.	1	$16
IBSA Pharma Inc.	1	$14
Neurocrine Biosciences, Inc.	1	$13
Avion Pharmaceuticals	1	$11

How this compares

$32,354 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan →

Medicare billing

Part B allowed, 2024

$114,372

Medicare patients

354

Services billed

2,908

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Bay City

Derrick WilliamsonSouthfield$9.9M
Rebecca RivardRoseville$7M
Paul BensonBerkley$4.2M
Michael HafranEast Lansing$2.7M
Mitzie HewittBuckley$1.3M
Loren ChudlerSouthfield$1.3M
Solomon AmsterWhite Lake$981K
Matt RosenbergJackson$559K
Rhonda MejeurGrand Rapids$493K
Steve LasaterSaint Johns$291K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →